See what questions
a doctor would ask.
The most prevalent neurological condition in HIV patients is toxoplasmosis encephalitis, especially in those who arenít taking prophlaxis. It was also more common in HIV patients who were at a high risk of HIV progression and death. HAART has helped to greatly reduce the risk of toxoplasmosis encephalitis and hence has nearly halved the deaths due to this condition. Further studies found that the risk of developing toxoplasmosis encephalitis was reduced by previous exposure to antiretroviral therapy, the use of prophylaxis against toxoplasmosis encephalitis and a stronger immune system at the time of neurological diagnosis. This results support the idea that HAART should be used before there is a high risk of clinical progression and taking prophylaxis by immunosuppressed patients where HAART has failed.
Source: summary of medical news story as reported by Aids Map
About: Researchers examine how to reduce toxoplasmosis encephalitis in HIV patients
Date: 25 November 2004
Source: Aids Map
Author: Michael Carter
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City